Related Experiment Video
Updated: May 30, 2026

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
A gain-of-function germline mutation in Drosophila ras1 affects apoptosis and cell fate during development
Christopher Gafuik1, Hermann Steller
1Howard Hughes Medical Institute, The Rockefeller University, New York, New York, United States of America.
Abstract:
The RAS/MAPK signal transduction pathway is an intracellular signaling cascade that transmits environmental signals from activated receptor tyrosine kinases (RTKs) on the cell surface and other endomembranes to transcription factors in the nucleus, thereby linking extracellular stimuli to changes in gene expression. Largely as a consequence of its role in oncogenesis, RAS signaling has been the subject of intense research efforts for many years. More recently, it has been shown that milder perturbations in Ras signaling during embryogenesis also contribute to the etiology of a group of human diseases. Here we report the identification and characterization of the first gain-of-function germline mutation in Drosophila ras1 (ras85D), the Drosophila homolog of human K-ras, N-ras and H-ras. A single amino acid substitution (R68Q) in the highly conserved switch II region of Ras causes a defective protein with reduced intrinsic GTPase activity, but with normal sensitivity to GAP stimulation. The ras1(R68Q) mutant is homozygous viable but causes various developmental defects associated with elevated Ras signaling, including cell fate changes and ectopic survival of cells in the nervous system. These biochemical and functional properties are reminiscent of germline Ras mutants found in patients afflicted with Noonan, Costello or cardio-facio-cutaneous syndromes. Finally, we used ras1(R68Q) to identify novel genes that interact with Ras and suppress cell death.
Insights
Researchers identified the first gain-of-function mutation in Drosophila ras1, a homolog of human RAS genes. This mutation causes developmental defects, mirroring human RASopathies like Noonan syndrome, and aids in discovering new interacting genes.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- The RAS/MAPK pathway is crucial for transmitting signals from cell surface receptors to the nucleus, regulating gene expression.
- Dysregulation of RAS signaling is implicated in oncogenesis and developmental disorders.
- Germline mutations in RAS genes contribute to human diseases such as Noonan syndrome.
Purpose of the Study:
- To identify and characterize the first gain-of-function germline mutation in Drosophila ras1, the homolog of human RAS genes.
- To investigate the functional consequences of this mutation on development.
- To utilize the mutant to discover novel interacting genes involved in RAS signaling.
Main Methods:
- Identification and characterization of a Drosophila ras1 gain-of-function mutation (ras1(R68Q)).
- Biochemical analysis of the mutant Ras protein's GTPase activity and GAP sensitivity.
- Phenotypic analysis of developmental defects in homozygous mutant flies.
- Genetic screens to identify interacting genes that suppress lethality or developmental defects.
Main Results:
- A single amino acid substitution (R68Q) in the switch II region of Drosophila Ras1 was identified as a gain-of-function mutation.
- The ras1(R68Q) mutant exhibits reduced intrinsic GTPase activity but normal GAP sensitivity.
- Homozygous mutant flies display developmental defects, including altered cell fate and ectopic cell survival in the nervous system, indicative of elevated Ras signaling.
- Novel interacting genes that suppress cell death were identified using the ras1(R68Q) mutant.
Conclusions:
- The Drosophila ras1(R68Q) mutation serves as a valuable model for studying RASopathies.
- This study provides insights into the biochemical and developmental consequences of germline RAS mutations.
- The identified interacting genes offer potential targets for understanding and treating RAS-related developmental disorders.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a superfamily...

